Description |
DNA topoisomerase I |
tripartite motif containing 32 |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction) ( 28560309)
- Antipsychotic drug-induced weight gain in schizophrenia ( 31447353)
- Cholesterol, total ( 24097068 20686565)
- LDL cholesterol ( 24097068 20686565)
- LDL cholesterol levels ( 28334899)
- LDL cholesterol levels x long total sleep time interaction (2df test) ( 31719535)
- LDL cholesterol levels x short total sleep time interaction (2df test) ( 31719535)
- Male-pattern baldness ( 28196072)
- Metabolite levels ( 23823483)
- Total cholesterol levels ( 28334899)
- Urate levels ( 31578528)
|
- Estimated glomerular filtration rate ( 31015462)
|
Interacting Genes |
59 interacting genes:
APAF1
APP
ATM
BARD1
BRCA1
BTBD1
BTBD2
BUB3
CASP3
CASP6
CDK8
CKAP5
CSNK2A1
CSNK2A2
DDB2
ELK3
ERCC8
ERG
FSHR
GEMIN4
IL7R
IRF4
IRF8
IRF9
JAK1
JUN
KMT2A
LIG4
LSM4
MDM2
NCL
NCOA6
PDE10A
PPP2R2B
PRB1
PRKDC
PYGM
RBL1
RBL2
RCVRN
SF3B1
SFPQ
SNRNP70
SNW1
SRPK2
SRSF1
SRSF11
SUMO1
SYMPK
TARBP2
TDP1
TOPORS
TP53
TRIM32
TUBD1
U2AF2
UBE2I
XRCC5
XRCC6
|
41 interacting genes:
ABI2
ATXN1
CLIP4
GLIS2
HSPA4
IQCB1
IRAK1
KCTD9
MID2
MYCN
NDRG2
PDE9A
PIAS3
PIAS4
PTCD2
PTPN11
RABAC1
RNF208
RNF41
SCGB1A1
SDCBP
STING1
SYT6
TOP1
TRIM23
TRIM27
TRIM5
TRIM72
UBC
UBE2D1
UBE2D2
UBE2D3
UBE2E1
UBE2E2
UBE2E3
UBE2N
UBE2U
UBQLN1
UBQLN4
VPS11
XIAP
|
Entrez ID |
7150 |
22954 |
HPRD ID |
00535 |
03797 |
Ensembl ID |
ENSG00000198900
|
ENSG00000119401
|
Uniprot IDs |
P11387
Q9BVT2
|
A0A024R843
Q13049
|
PDB IDs |
1A31
1A35
1A36
1EJ9
1K4S
1K4T
1LPQ
1NH3
1R49
1RR8
1RRJ
1SC7
1SEU
1T8I
1TL8
|
2CT2
5FEY
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|